Lv5
970 积分 2025-01-12 加入
Next-generation programmable cell therapies for precision medicine
7天前
已完结
B cell depletion in autoimmune disease: in vivo CAR-T or T cell engagers?
8天前
已完结
In vivo generation of anti-BCMA CAR-T cells in relapsed or refractory multiple myeloma: a phase 1 study
9天前
已完结
In vivo site-specific engineering to reprogram T cells
21天前
已完结
Fluorinated lipid nanoparticles enable in vivo CAR-macrophage therapy in solid tumor and enhance anti PD-L1 immunotherapy
24天前
已完结
Co-infusion of CD19-targeting and BCMA-targeting CAR-T cells for treatment-refractory systemic lupus erythematosus: a phase 1 trial
24天前
已完结
Cancer mRNA vaccines: clinical advances and future opportunities
27天前
已完结
Personalized mRNA vaccine induces strong, durable immunity in hard-to-treat breast cancer
29天前
已完结
In vivo CAR engineering for immunotherapy
29天前
已完结
Tumour-derived small extracellular vesicles act as a barrier to therapeutic nanoparticle delivery
29天前
已完结
皖公网安备34019202002308
